88
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain

, &
Pages 467-474 | Published online: 09 Jan 2014

References

  • Suttie JW. Warfarin and vitamin K. Clin. Cardiol.13(4 Suppl. 6), VI16–VI18 (1990).
  • Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation114(2), 119–125 (2006).
  • Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA285(18), 2370–2375 (2001).
  • Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general Medicare population: a 10 year perspective (1992 to 2002). Stroke37(8), 1969–1974 (2006).
  • Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet1(8631), 175–179 (1989).
  • Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J. Thromb. Thrombolysis21(1), 23–29 (2006).
  • Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest133(Suppl.), S160–S198 (2008).
  • Nutescu EA, Shapiro NL, Ibrahim S, West P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin. Drug Saf.5(3), 433–451 (2006).
  • Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann. Intern. Med.121(9), 676–683 (1994).
  • Spandorfer JM, Merli GJ. Outpatient anticoagulation issues for the primary care physician. Med. Clin. North Am.80(2), 475–491 (1996).
  • Tapson VF, Hyers TM, Waldo AL et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch. Intern. Med.165(13), 1458–1464 (2005).
  • Verhovsek M, Motlagh B, Crowther MA et al. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr.8, 13 (2008).
  • Wild D, Murray M, Shakespeare A, Reaney M, von Maltzahn R. Patient-reported treatment satisfaction measures for long-term anticoagulant therapy. Expert Rev. Pharmacoeconomics Outcomes Res.8(3), 291–299 (2008).
  • Joffe H, Yardley L. Content and thematic analysis. In: Research Methods for Clinical and Health Psychology. Marks DF, Yardley L (Eds). Sage Publications, London, UK (2004).
  • Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qualitative Res.8(1) 137–152 (2008).
  • Lancaster TR, Singer DE, Sheehan MA et al. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Arch. Intern. Med.151(10), 1944–1949 (1991).
  • Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F. The management of oral anticoagulant therapy: the patient’s point of view. Thromb. Haemost.83(1), 49–53 (2000).
  • Das AK, Willcoxson PD, Corrado OJ, West RM. The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation. Age Ageing36(1), 95–97(2007).
  • Casais P, Meschengieser SS, Sanchez-Luceros A, Lazzari MA. Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life. Curr. Med. Res. Opin.21(7), 1085–1090 (2005).
  • Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: views of health professionals, older respondents and their carers. Med. J. Aust.186(4), 175–180 (2007).
  • Dantas GC, Thompson BV, Manson JA, Tracy CS, Upshur RE. Respondents’ perspectives on taking warfarin: qualitative study in family practice. BMC Fam. Pract.5, 15–23, 21–27 (2004).
  • Fihn SD, McDonell M, Martin D et al. Warfarin Optimized Outpatient Follow-up Study Group. Risk factors for complications of chronic anticoagulation. A multicenter study. Ann. Intern. Med.118(7), 511–520 (1993).
  • Casais P, Luceros AS, Meschengieser S, Fondevila C, Santarelli MT, Lazzari MA. Bleeding risk factors in chronic oral anticoagulation with acenocoumarol. Am. J. Hematol.63(4), 192–196 (2000).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.